Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...